Link copied to clipboard!

XCODE LIFE launches the world’s first ‘South Asian and Indian Ancestry Genetic Test

IMT News Desk
IMT News Desk
· Updated Apr 8, 2020 · 3 min read

Xcode, an innovative personal genomics company based out of Chennai was in the city today, to announce the Worldwide launch of  the first of its kind ‘South Asian Ancestry Genetic Test’ that will  trace one’s ancestry in the global and South Asian sub-population level.  The test will reveal information about oneself comparing the DNA samples of each individual with more than 35 ethnic groups in India, Pakistan, Nepal, Bangladesh and other regional countries to provide a detailed ancestry break-up.

Talking on this Occasion, Dr Abdur Rub, Co-Founder and Chief Technology Officer, Xcode Life Sciences said, “Our unique heritage, our unique history, the history of our ancestors, is living within each of us! You may be 20, 30 or 50 years old, but your genes are 3 billion years old. For the first time in human history, genetic technology makes it possible to uncover this unique past that each of us carry in us. I am very excited that Xcode is launching world’s first ‘South Asian Ancestry Genetic Test’ through which your DNA is matched with more than 35 ethnic groups in India and other groups worldwide, and your most recent paternal ancestor.”

Present at the launch to to spread awareness on using genomics to deduce Indian ancestry was Dr Analabha Basu, Associate Professor, National Institute of Biomedical Genomics. Sharing his views on the subject, he said, “Knowledge about the origin of the human species as a whole has the potential to reshape our society. The more we learn about our diversity, the more we learn how connected we are. It can lead to path-breaking medical discoveries and pave the way forward to research based on our DNA patterns.”

Xcode will also help individuals to trace their paternal ancestry by evaluating your DNA which will decode ancient migratory patterns of their forefathers. Tracing our family tree is an activity that features in all our childhoods, but did any of us manage to reach beyond our grandparents or our great grandparents? All of us are products of generations of ancestry with a rich history and heritage, all embedded in our genes waiting to be uncovered. Every cell in our body contains DNA which can reveal everything from our family history to our ancestral migratory patterns and with Xcode’s innovative DNA ancestry test, you now have the chance to unravel this rich history  written in your DNA.

Speaking about the company goal and expansion plans Dr. Abdur Rub said, “Our goal is to bring down the disease burden of metabolic disease in India and across the world. We intend to grow to a 1 million-customer base in the next 3 years. We are expanding our global footprint and are known for both genomic research as well as high quality genetic tests, reports and related services.”

It’s time to celebrate your rich history and heritage- so come along with us as we undertake this fascinating journey through your DNA.

Read Next

Cipla, Natco, Hetero and Annora Win Key Generic Drug Supply Contracts in China
Asia
November 12, 2025

Cipla, Natco, Hetero and Annora Win Key Generic Drug Supply Contracts in China

In a significant boost for India’s pharmaceutical exports, Cipla, Natco Pharma, Hetero Labs, and Annora Pharma have been selected by China under its volume-based procurement (VBP) program to supply essential generic medicines to public hospitals. The move marks a breakthrough for Indian drugmakers in gaining access to China’s tightly regulated healthcare market, which has traditionally […]
Article by: IMT News Desk
Gavi to boost access to life-saving human rabies vaccines in over 50 countries: Gavi, WHO and UAR
Asia
June 19, 2024

Gavi to boost access to life-saving human rabies vaccines in over 50 countries: Gavi, WHO and UAR

The first round of applications will be accepted by mid-July 2024 Gavi, the Vaccine Alliance, in collaboration with partners, is announcing support for human rabies vaccines for post-exposure prophylaxis (PEP) as part of routine immunisation. Eligible countries are receiving guidance on how to access these vaccines under Gavi’s cofinancing policy. The first round of applications […]
Article by: IMT News Desk
Marengo Asia Hospitals, Intermed Hospital join hands to establish cardiac centre in Mongolia
Asia
February 27, 2024

Marengo Asia Hospitals, Intermed Hospital join hands to establish cardiac centre in Mongolia

Marengo Asia Hospitals will conduct comprehensive assessments and gap analysis at Intermed Hospital, facilitating training initiatives The initiative is aimed at offering advanced treatments for cardiac health to the population of Mongolia, leveraging the pivotal role and expertise of the Marengo CIMS Cardiac Sciences team across various aspects of CoE collaboration. Marengo Asia Hospital, India […]
Article by: IMT News Desk
Takeda emphasises cross-sectoral alliances to address burden of vector-borne infectious diseases
Asia
December 19, 2023

Takeda emphasises cross-sectoral alliances to address burden of vector-borne infectious diseases

The AVPN South Asia Summit in December 2023 brought together social impact thought leaders and industry experts from South Asian countries Takeda Biopharmaceuticals India (formerly Baxalta Bioscience India) – a global values-based, R&D-driven biopharmaceutical leader – presented an industry perspective on the substantial need for vaccine equity and novel strategies for vector-borne disease financing at […]
Article by: IMT News Desk